Metabolic & Cardiometabolic
arabinoxylan dietary fiber decreases LDL cholesterol
In plain terms: Does the wheat fiber arabinoxylan actually lower LDL cholesterol?
Arabinoxylan does modestly lower LDL in small trials via bile-acid loss, but calling it the single "most effective" fiber overstates the evidence versus beta-glucan and psyllium.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
<!-- vault-context --> Norwitz **affirms** this claim. Consensus below reflects independent literature only.
The evidence (9)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Ho 2016 · Br J Nutr | meta-analysis | supports | high | Meta-analysis of 58 RCTs shows viscous soluble cereal fibre (oat beta-glucan, arabinoxylan-class) lowers LDL-C ~0.19 mmol/L, supporting the mechanism. |
| Lu 2000 · Am J Clin Nutr | RCT | mixed | moderate | Wheat arabinoxylan reduced postprandial glucose in normoglycemic subjects; lipid/LDL effects not established in this acute study. |
| Hartvigsen 2014 · Eur J Clin Nutr | RCT | tested-null | moderate | Concentrated arabinoxylan improved postprandial glucose/appetite in metabolic syndrome but did not demonstrate meaningful LDL lowering. |
| Garcia 2006 · Br J Nutr | RCT | mixed | moderate | 15g/day arabinoxylan lowered fasting glucose, triglycerides and apoA-1 but showed no significant effect on apoB or LDL-related fractions. |
| Lancaster 2022 · Cell Host Microbe | RCT | supports | moderate | n=18 crossover purified-fiber feeding: arabinoxylan significantly cut LDL & raised bile acids; the exact paper Norwitz cites, small n. |
| Whitehead A, et al. 2014 · Am J Clin Nutr | meta-analysis | supports | high | Meta-analysis confirms viscous cereal soluble fibre >=3g/day lowers LDL-C, the mechanistic class to which wheat arabinoxylan belongs. |
| Schioldan 2018 · Eur J Nutr | RCT | mixed | moderate | 4-wk arabinoxylan+resistant-starch diet in metabolic syndrome improved postprandial metabolism but did not significantly lower fasting LDL vs refined-carb. |
| Lu 2004 · Diabetologia/Eur J Clin Nutr | RCT | mixed | low | Arabinoxylan-rich wheat fiber improved glycaemic control in T2D; lipid/LDL benefit not the primary or robust finding. |
| Hall 2019 · Cell Metab | RCT | tested-null | moderate | Context disconfirmer: fiber alone is one lever; whole-diet trials show LDL driven by many factors, AX not uniquely dominant. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.